Breakthrough technology - DKD - exclusive distributor for the Czech and Slovak markets

Bio Preventive Medicine (BPM) is the best biomarker solution and technology. The company's expertise in the field of diabetic kidney disease (DKD) and non-proteinuric kidney diseases led to the development of the breakthrough technology DNlite-IVD103. It is the world's first regulatory-approved non-invasive urine test for predicting DKD progression.

DNlite-IVD103 is the first ELISA kit that accurately determines DKD. It can effectively answer the kidney condition of a patient with diabetes during the next 1-2 years. If there is a risk of a progressive decline in glomerular filtration rate (GFR) found, patients can be advised to start the right treatment earlier and take advantage of the critical window for its clinical effect, and even recovery. Prediction of decline or renal complications demonstrable high-quality care for the patient with DKD.

We are honored to bring this breakthrough technology to the Czech and Slovak markets.

For more information, contact Bc. Martina Fráňová:
franova@promedeuslab.cz
+420  732  240 848

Or visit our website:
 Human uPTM3-DKD ELISA | PromedeusLab